skip to the main content area of this page

November 2020 – UNODC: Commission on Narcotic Drugs decision on international control of AB-FUBINACA, 5F-AMB-PINACA, 5F-MDMB-PICA, 4F-MDMB-BINACA, 4-CMC, N-ethylhexedrone, alpha-PHP, Flualprazolam, Etizolam, DOC and one precursor enters into force

VIENNA, Austria – November 2020: The decision of the Commission on Narcotic Drugs (CND) during its 63nd Sessionfrom 2 to 6 March 2020to add 2,5-Dimethoxy-4-chloroamphetamine (DOC) to Schedule I, AB-FUBINACA5F-AMB-PINACA5F-MDMB-PICA4F-MDMB-BINACA, 4-CMC (4-chloromethcathinone), N-ethylhexedronealpha-PHP to Schedule II and Flualprazolam and Etizolam to Schedule IV of the Convention on Psychotropic Substances of 1971 entered into force on 3 November 2020 

Similarly, the decision to place the precursors Methyl alpha-phenylacetoacetate (MAPA) (including its optical isomers) to Table I of the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988, entered into force. 

Previously, on 7 May 2020, the decision adopted by the CND during its 63nd Session to addCrotonylfentanyl and Valerylfentanyl to Schedule I of the Single Convention on Narcotic Drugs of 1961 entered into force. 

go back